Brief: Devyser Genomic Laboratories Signs First Commercial Agreement
Jan 17 (Reuters) - Devyser Diagnostics AB DVYSR.ST :
* DEVYSER GENOMIC LABORATORIES SIGNS FIRST COMMERCIAL
AGREEMENT
* INITIAL PERIOD FOR AGREEMENT IS TWO YEARS WITH ESTIMATED
TOTAL
REVENUE AMOUNTING UP TO APPROXIMATELY 25 MSEK WHERE OF
APPROXIMATELY UP TO 6 MSEK IN 2024
Source text for Eikon: ID:nMFN3rJQZ5
Further company coverage: DVYSR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Devyser Diagnostics AB
See all newsBrief: Devyser Awarded Tender In Italy Valued At SEK 8.9 Million
Brief: Devyser Diagnostics Appoints Niklas Axelsson As CFO
Sweden's Devyser Q1 net sales rise 12.9%, operating profit turns positive
Brief: Devyser Q1 Sales SEK 61.8 Million
Brief: Devyser Completes Cybergene Acquisition, Carries Out Compensation Share Issue